The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
By A Mystery Man Writer
Description
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://i1.rgstatic.net/publication/378229965_Advances_in_Non-Small_Cell_Lung_Cancer_NSCLC_Treatment-A_Paradigm_Shift_in_Oncology/links/65ce2fece51f606f99731c0c/largepreview.png)
PDF) Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](http://www.ncc.go.jp/en/ogp/10.png)
CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC, identified using LC-SCRUM-Asia genomic screening platform -A step further to precision medicine
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://europepmc.org/articles/PMC8687755/bin/nihms-1760523-f0004.jpg)
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://www.biorxiv.org/content/biorxiv/early/2021/12/14/2021.10.20.464849/F1.large.jpg)
Combinatorial tumor suppressor inactivation efficiently initiates
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://www.abcam.com/ps/products/129/ab129155/Images/ab129155-143143-anti-ltk-antibody-epr51752-western-blot.jpg)
Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12957-023-03057-y/MediaObjects/12957_2023_3057_Fig5_HTML.png)
Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer, World Journal of Surgical Oncology
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://www.biorxiv.org/content/biorxiv/early/2021/12/14/2021.10.20.464849/F8.large.jpg)
Combinatorial tumor suppressor inactivation efficiently initiates
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://kokyurinsho.com/datas/media/10000/md_2616.png)
LC-SCRUMによる新規非小細胞肺癌ドライバーの同定/ゲノム編集による治療を臓器特異的,病態特異的に届ける/コロナワクチン免疫の経時的な減衰
![The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41416-023-02301-2/MediaObjects/41416_2023_2301_Fig1_HTML.png)
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
from
per adult (price varies by group size)